Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAY.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CP.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.45NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.5.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.41NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.75.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CR.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BT.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XMNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.70NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.63NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.8.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EC.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XLNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.87 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.23.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XNNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.111 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CE.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XGNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.37 (Lambda)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used